Published in J Physiol on March 01, 1978
Alpha-drenergic inhibition of calcium-dependent potentials in rat sympathetic neurones. J Physiol (1980) 2.18
Effects of adrenaline and of spontaneous labour on the secretion and absorption of lung liquid in the fetal lamb. J Physiol (1983) 1.77
Synergistic stimulation of Ca2+ uptake by glucagon and Ca2+-mobilizing hormones in the perfused rat liver. A role for mitochondria in long-term Ca2+ homoeostasis. Biochem J (1986) 1.20
Potentiation of alpha 1-adrenergic responses in rat liver by a cAMP-dependent mechanism. Proc Natl Acad Sci U S A (1984) 1.17
Calcium: its modulation in liver by cross-talk between the actions of glucagon and calcium-mobilizing agonists. Biochem J (1993) 1.10
The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in the rat in vivo and in vitro. Br J Pharmacol (1986) 1.05
Femoral arterial and venous catheterization for blood sampling, drug administration and conscious blood pressure and heart rate measurements. J Vis Exp (2012) 1.02
Parotid secretion of fluid and amylase in rabbits during feeding. J Physiol (1980) 1.01
Vascular and metabolic effects of circulating epinephrine and norepinephrine. Concentration-effect study in dogs. J Clin Invest (1979) 0.92
Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev (2009) 0.87
A dopaminergic receptor modulates catecholamine release from the cat adrenal gland. J Physiol (1985) 0.85
Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma. Br J Pharmacol (1979) 0.84
Rat endometrial bioelectric activity in vivo and in vitro: effects of adrenaline. J Physiol (1983) 0.83
Changes in plasma noradrenaline and adrenaline associated with central and peripheral thermal stimuli in the pig. J Physiol (1981) 0.83
Potential contribution of vasoconstriction to suppression of heat loss and homeothermic regulation in UCP1-deficient mice. Pflugers Arch (2006) 0.81
Mechanism of postarrhythmic renal vasoconstriction in the anesthetized dog. J Clin Invest (1979) 0.78
Differential Inhibition of Ca2+ channels by alpha2-adrenoceptors in three functional subclasses of rat sympathetic neurons. J Neurophysiol (2008) 0.77
On the significance of monoamines and their metabolites in the cerebrospinal fluid of the sheep. J Physiol (1984) 0.76
Lack of integrative control of body temperature after capsaicin administration. Korean J Intern Med (2000) 0.76
Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle. Br J Pharmacol (1990) 0.75
Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma. Indian J Endocrinol Metab (2015) 0.75
The effect of adrenal demedullation on cardiovascular responses to environmental stimulation in conscious rats. Br J Pharmacol (1986) 0.75
Plasma catecholamines in Down's syndrome, at rest and during sympathetic stimulation. J Neurol Neurosurg Psychiatry (1985) 0.75
Control of glycogenolysis and blood flow by arterial and portal adrenaline in perfused liver. Biochem J (1991) 0.75
A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther (1962) 11.93
Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci (1976) 5.54
Plasma adrenaline and noradrenaline after phenoxybenzamine administration, and during haemorrhagic hypotension, in normal and adrenalectomized dogs. Br J Pharmacol Chemother (1959) 1.31
A sensitive radioenzymatic assay for dopamine, norepinephrine, and epinephrine in plasma and tissue. Endocrinology (1976) 1.26
Letter: Sympathoadrenal medullary activity in young, spontaneously hypertensive rats. Nature (1975) 1.21
Catecholamines in blood. J Pharm Pharmacol (1976) 1.08
Effects of halothane on plasma catecholamines. Anesthesiology (1974) 0.95
Plasma norepinephrine and dopamine-beta-hydroxylase in genetic hypertensive rats. Life Sci (1976) 0.93
Catecholamine Concentrations: Changes in Plasma of Rats during Estrous Cycle and Pregnancy. Science (1966) 0.93
Plasma catecholamines: arterial-venous difference and the influence of body temperature. Life Sci (1975) 0.92
Effects of handling, decapitation, anesthesia, and surgery on plasma noradrenaline levels in the white rat. Can J Physiol Pharmacol (1977) 0.90
Proceedings: The sympathetic nervous system and renovascular hypertension in the rat. Br J Pharmacol (1976) 0.87
Effect of tyramine and guanethidine on dopamine-beta-hydroxylase activity and norepinephrine concentrations in vesicular fraction of the heart and plasma of rats. Life Sci (1977) 0.86
Assay of cathecholamines in human plasma: studies of a single isotope radioenzymatic procedure. Life Sci (1976) 0.84
Circadian rhythm in blood and brain biogenic amines and other biochemical changes in rabbits. Brain Res (1974) 0.82
A sensitive assay for the determination of dopamine in plasma. Scand J Clin Lab Invest (1973) 0.82
An automated method for determination of noradrenaline and adrenaline in tissues and biological fluids. Anal Biochem (1968) 0.81
Dopamine in the blood of the ruminant. J Physiol (1970) 0.81
The presence of dopamine in cat spleen and blood. J Pharm Pharmacol (1969) 0.81
Thyroid secretion in the unanesthetized, stress-free rat and its suppression by pentobarbital. Neuroendocrinology (1972) 0.80
Resting secretion of dopamine from the adrenal glands of the cat in vivo. Experientia (1967) 0.80
Dopamine secretion from the isolated perfused sheep adrenal. Acta Physiol Scand (1970) 0.80
Selective antagonists of benzodiazepines. Nature (1981) 3.03
Some pharmacological actions of the beta-adrenolytic agent Ro 3-3528 (6,7-dimethyl-alpha-[(isopropylamino) methyl]-2-benzofuranmethanol Hydrochloride). Angiologica (1967) 2.10
Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat. J Physiol (1965) 1.92
Dual site of action of phenoxybenzamine in the cat's spleen; blockade of alpha-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine. Experientia (1964) 1.83
Possible involvement of GABA in the central actions of benzodiazepines. Adv Biochem Psychopharmacol (1975) 1.63
Potentiation by tetraethylammonium of the response of the cat spleen to postganglionic sympathetic nerve stimulation. J Pharmacol Exp Ther (1967) 1.54
Pharmacology of midazolam. Arzneimittelforschung (1981) 1.52
Chemical sympathectomy of the cat with 6-hydroxydopamine. J Pharmacol Exp Ther (1969) 1.46
Co-localization of GABA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies. Nature (1985) 1.35
Mechanism of amphetamine accumulation in the isolated perfused heart of the rat. J Pharm Pharmacol (1968) 1.30
[Research on the problem of a cholinergic link in postganglionic sympathetic transmission]. Helv Physiol Pharmacol Acta (1966) 1.28
A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, beta-carbolines, and phenobarbitone. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.25
The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.21
Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.20
Liberation of p-hydroxynorephedrine from cat spleen by sympathetic nerve stimulation after pretreatment with amphetamine. Life Sci (1966) 1.19
Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience (1998) 1.18
Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat. J Pharmacol Exp Ther (1966) 1.17
The effect of diazepam on spinal cord activities: possible sites and mechanisms of action. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.17
On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn Schmiedebergs Arch Pharmakol (1969) 1.15
LSD as an agonist of dopamine receptors in the striatum. Nature (1974) 1.12
Pre- and postjunctional supersensitivity of the mesenteric artery preparation from normotensive and hypertensive rats. Naunyn Schmiedebergs Arch Pharmakol (1970) 1.11
Effect of activation of the H1 receptor on coronary hemodynamics in man. Circulation (1986) 1.09
Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology (Berl) (1982) 1.03
Adrenergic transmitter changes and response to sympathetic nerve stimulation after differing pretreatment with alpha-methyldopa. Br J Pharmacol Chemother (1967) 1.03
Effect of drugs and cations on ultrastructure and 5-hydroxytryptamine content of blood platelets. J Pharmacol Exp Ther (1967) 1.01
Some basic aspects of reversible inhibitors of monoamine oxidase-A. Acta Psychiatr Scand Suppl (1990) 1.00
Interaction of benzodiazepines with neuroleptics at central dopamine neurons. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.98
Effects of diethyl ether, halothane, ketamine and urethane on sympathetic activity in the rat. Eur J Pharmacol (1987) 0.98
Blood sampling by chronic cannulation technique for reliable measurements of catecholamines and other hormones in plasma of conscious rats. J Pharmacol Methods (1981) 0.98
Cation dependence of the noradrenaline-releasing action of tyramine. Eur J Pharmacol (1969) 0.96
Cardiovascular effects of histamine infusion in man. J Cardiovasc Pharmacol (1983) 0.92
Effects of two benzodiazepines, phenobarbitone, and baclofen on synaptic transmission in the cat cuneate nucleus. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.92
Effects of clozapine on cerebral catecholaminergic neurone systems. Br J Pharmacol (1972) 0.91
[Hermansky-Pudlak syndrome in a Valais village]. Helv Paediatr Acta (1983) 0.91
Changes in plasma catecholamines in response to reflex modulation of sympathetic vasoconstrictor tone by cardiopulmonary receptors. Clin Sci (Lond) (1985) 0.91
Blockade of central 5-hydroxytryptamine receptors by methiothepin. Naunyn Schmiedebergs Arch Pharmacol (1972) 0.90
Storage of 5-hydroxytryptamine in megakaryocytes. J Cell Biol (1972) 0.89
Formation of 5-hydroxytryptophol by blood platelets after thrombin and reserpine. Experientia (1965) 0.89
Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels. J Neurochem (1981) 0.88
Transfer and storage of biogenic monoamines in subcellular organelles of blood platelets. Prog Brain Res (1969) 0.87
Mass spectrometric analysis of human soluble catechol O-methyltransferase expressed in Escherichia coli. Identification of a product of ribosomal frameshifting and of reactive cysteines involved in S-adenosyl-L-methionine binding. Eur J Biochem (1994) 0.87
Uptake, release, and subcellular localization of 1-methyl-4-phenylpyridinium in blood platelets. J Neurochem (1987) 0.87
The effect of stimulation of sympathetic nerves in the cat treated with reserpine, alpha-methyldopa and alpha-methylmetatyrosine. Br J Pharmacol Chemother (1966) 0.86
Plasma catecholamines in rats exposed to cold: effects of ganglionic and adrenoreceptor blockade. Eur J Pharmacol (1981) 0.86
Characterization of [3H]Ro 16-6491 binding to digitonin solubilized monoamine oxidase-B and purification of the enzyme from human platelets by affinity chromatography. Biochem Pharmacol (1990) 0.86
Diminished effects of sympathetic nerve stimulation in cats pretreated with disulfiram; liberation of dopamine as sympathetic transmitter. Life Sci (1965) 0.86
Parathyroid hormone responses to catecholamines and to changes of extracellular calcium in cows. J Clin Invest (1978) 0.85
Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma. Br J Pharmacol (1979) 0.84
Dopaminergic phenotype induced by oestrogens in a human neuroblastoma cell line. Eur J Neurosci (1997) 0.84
[3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B. Eur J Pharmacol (1989) 0.84
Renal dysfunction as a possible cause of essential hypertension in predisposed subjects. Kidney Int (1983) 0.84
Biological basis of drug-induced tolerance, rebound, and dependence. Contribution of recent research on benzodiazepines. Pharmacopsychiatry (1986) 0.84
[Antidromic activity induced by acetylcholine in the cardiac sympathetic nerve, and noradrenaline liberation under the influence of guanethidine]. Helv Physiol Pharmacol Acta (1968) 0.83
The effect of alpha-methyl-tyrosine on peripheral sympathetic transmission. Life Sci (1966) 0.83
Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr Scand (1990) 0.82
Quantitation of low abundance mRNAs in glial cells using different polymerase chain reaction (PCR)-based methods. Brain Res Brain Res Protoc (1997) 0.82
[Pharmacology and toxicology of the anticonvulsant agent clonazepam]. Arzneimittelforschung (1973) 0.82
Estrogenic control of monoamine oxidase A activity in human neuroblastoma cells expressing physiological concentrations of estrogen receptor. Eur J Pharmacol (1995) 0.82
Muscarinic postsynaptic events in the cat superior cervical ganglion in situ. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.82
Monoamine oxidase B expression is selectively regulated by dexamethasone in cultured rat astrocytes. Brain Res (1996) 0.82
Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.82
Peripheral catecholamine release by alpha-latrotoxin in the rat. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.81
Quantitative aspects of the replacement of norepinephrine by dopamine as a sympathetic transmitter after inhibition of dopamine-beta-hydroxylase by disulfiram. J Pharmacol Exp Ther (1967) 0.81
The effect of diphenylhydantoin, diazepam and clonazepam on the activity of Purkinje cells in the rat cerebellum. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.81
Pharmacology of benzodiazepine antagonists. Pharmacopsychiatry (1985) 0.81
Mechanisms of catecholamine accumulation in adrenal chromaffin granules. Brain Res (1973) 0.80
The effects of l,l-dimethyl-4-phenyl-piperazinium (DMPP) in the cat superior cervical ganglion in situ. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.80
Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain. Adv Biochem Psychopharmacol (1974) 0.80
Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex. J Neural Transm Gen Sect (1995) 0.80
Plasma catecholamines and blood pressure responses to the carotid baroreceptor reflex in essential hypertension. Clin Sci (Lond) (1979) 0.80
Storage pool disease: comparative fluorescence microscopical, cytochemical and biochemical studies on amine-storing organelles of human blood platelets. Br J Haematol (1979) 0.80
[Qualitatively and quantitatively different effects of alpha-methyldopa treatment on cats according to a dosage scheme]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.80
[Synthesis of bradykinin analogs with D-amino acids (all-D-bradykinin and all-D-retro-bradykinin)]. Helv Chim Acta (1966) 0.80
Effects of moclobemide, a new generation reversible Mao-A inhibitor, in a novel animal model of depression. Pharmacopsychiatry (1993) 0.80
Benzodiazepine interactions with GABA receptors. Neurosci Lett (1984) 0.79
Adrenal response in the calf to repeated simulated transport. Br Vet J (1990) 0.79
Selective suppression of rapid eye movement sleep (REMS) in cats by typical and atypical antidepressants. Adv Biochem Psychopharmacol (1982) 0.79
Estrogen modulation of catecholamine synthesis and monoamine oxidase A activity in the human neuroblastoma cell line SK-ER3. J Steroid Biochem Mol Biol (1993) 0.79
Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents. Circulation (1985) 0.79
Sequential changes in plasma renin activity and plasma catecholamines in mildly hypertensive patients during acute, furosemide-induced body-fluid loss. Eur J Clin Pharmacol (1983) 0.79
Diclofenac increases beta-endorphin plasma concentrations. J Int Med Res (1984) 0.79
Drugs and PGO waves in the lateral geniculate body of the curarized cat. IV. The effects of acetylcholine, GABA and benzodiazepines on PGO wave activity. Arch Int Pharmacodyn Ther (1976) 0.79
Blockade by mazindol of brain 5-HT depletion induced by p-chloromethamphetamine. J Pharm Pharmacol (1977) 0.78
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. Nephron (1981) 0.78
Identification of guanosine 5'-triphosphate and uridine 5'-triphosphate in subcellular monamine-storage organelles. Biochem J (1970) 0.78
L-cycloserine: behavioural and biochemical effects after single and repeated administration to mice, rats and cats. Neuropharmacology (1986) 0.78
Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats. Pharmacol Biochem Behav (1981) 0.78
Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.78
[3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes. J Neurochem (1988) 0.78
Effects of several centrally active drugs on the sleep-wakefulness cycle of cats. Neuropharmacology (1979) 0.78
The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice. Eur J Pharmacol (1985) 0.77
Reduction by two benzodiazepines and pentobarbitone of the multiunit activity in substantia nigra, hippocampus, nucleus locus coeruleus and nucleus raphé dorsalis of encéphale isolé rats. Neuropharmacology (1983) 0.77
Postsynaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries. Neurosci Lett (1985) 0.77
Plasma adrenaline and noradrenaline concentrations in diabetic patients with and without autonomic neuropathy at rest and during sympathetic stimulation. Diabetologia (1982) 0.77
Benzodiazepines enhance the bicuculline-sensitive part of recurrent Renshaw inhibition in the cat spinal cord. Neurosci Lett (1982) 0.77
Immunoregulation mediated by the sympathetic nervous system, II. Cell Immunol (1981) 0.77
Environmental stimulation promotes changes in the distribution of phorbol ester receptors. Pharmacol Biochem Behav (1993) 0.77
Benzodiazepine receptors resolved. Experientia (1986) 0.77
Uptake and liberation of mepacrine in blood platelets. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.77
Antagonists of benzodiazepines: functional aspects. Adv Biochem Psychopharmacol (1983) 0.76